[TSX Venture Exchange] Palisade Bio, Inc. (PALI) +11.90% : Auto elettriche, A2A porta i lampioni – colonnine a Brescia (2025-03-11)

Company Logo

Palisade Bio, Inc. (PALI)


PALI Chart as of 2025-03-11

PALI Chart


Stock Information

CEO:
CFO:
Employees: 9
Address: 7750 El Camino Real, Carlsbad, CA, United States
Country: United States
Website: https://www.palisadebio.com
Listing Date:
Founded:
Founder:
Current Price: 0.9399999976158142 USD
Today Change: 11.90%
Outstanding Shares: 2,765,980
Volume: 97,489
Avg Volume: 461,950
Expert Target Price: 20.0000
(Institutions: 0)
EPS:
PER:
Dividend Date: 2019-07-18
Last Split Date: 2024-04-08
Last Split Factor: 1:15

Key Executives

Name Title Pay Year
Mr. J. D. Finley CEO, CFO & Director 791.33k
Dr. Mitchell Lawrence Jones M.D., Ph.D. COO & Chief Medical Officer 635k
Dr. Joerg Heyer Ph.D. Head of Translational Science & Medicine
Mr. Ryker Willie Senior VP of Finance & Corporate Controller

Financials

Income Statement

Metric Amount
Total Revenue 250,000
Cost Of Revenue
Gross Profit
Operating Income -12,845,000
Net Income -12,300,000

Balance Sheet

Metric Amount
Total Assets 14,052,000
Total Liabilities
Total Stockholder Equity

Cash Flow

Metric Amount
Total Cash From Operating Activities
Capital Expenditures

SEC Filings (Gemini Summaries)

AccNo Date Summary
0001172661-25-001261 2025-02-14 The filing defines CSS styles for text boxes and tables, including borders, padding, font sizes, colors, alignment, and word wrapping. Styles specify appearance for different table elements like headers, data cells, and inner tables.
0001493152-25-006500 2025-02-13 Form 4 filing by Mitchell Lawrence Jones, Chief Medical Officer of Palisade Bio, Inc. (PALI). Reports changes in beneficial ownership of securities. Earliest transaction date: 02/11/2025.
0001493152-25-006498 2025-02-13 Form 4 filing for Palisade Bio, Inc. (PALI) by John David Finley (CEO, CFO). Reports changes in beneficial ownership of securities. Filed 2/11/2025. Indicates director/officer status.
0001493152-24-050473 2024-12-17 This prospectus supplement updates a prior prospectus for Palisade Bio, Inc. It reduces the exercise price of 114,354 common stock warrants (originally issued Feb 2024) from $10.97 to $1.40, after a 1-for-15 reverse stock split. It also updates information about selling stockholders.
0001493152-24-050471 2024-12-17 This prospectus supplement updates Palisade Bio’s May 17, 2024 prospectus. It reduces the exercise price of 922,863 common stock warrants from $6.314 to $1.40. It also updates information regarding selling stockholders.

News Summary

Auto elettriche, A2A porta i lampioni – colonnine a Brescia
2025-02-11 07:00:00 | Hdmotori.it
I pali della luce possono essere trasformati in hub multifunzionali
Link

Najstarsze ślady prymitywnych pojazdów odkryte w USA – nie zgadniesz, jak bardzo są stare!
2025-02-25 17:00:03 | Antyweb.pl
Pierwszy pojazd transportowy w historii ludzkości. Była to konstrukcja z drewnianych pali i sunęła przede wszystkim przez mokradła.
Link

I lampioni che ricaricano le auto elettriche: parte la sperimentazione a Brescia
2025-02-12 09:29:00 | Smartworld.it
I lampioni che ricaricano le auto elettriche non sono un’utopia. Anzi, si tratta di un concetto che è stato già…
L’articolo I lampioni che ricaricano le auto elettriche: parte la sperimentazione a Brescia sembra essere il primo su Smartworld.
Link

Random Acts of Kindness
2025-02-13 21:47:42 | Psychology Today
Random Acts of Kindness Week is February 9th through the 15th. Learn about the benefits of kindness by reading more here.
Link

Zadzwonił na 112 i powiedział, że “kamienica się pali”. Bo nie mógł wejść do mieszkania
2025-02-28 11:17:11 | Tvn24.pl
47-latek nie mógł wejść do swojego mieszkania, więc postanowił zadzwonić na numer 112, informując, że “kamienica się pali”. Za bezpodstawne wezwanie służb odpowie przed sądem.
Link



Analysis of Today’s Move

Palisade Bio (PALI) likely experienced a stock rally today due to a confluence of factors, primarily related to positive sentiment regarding the company’s leadership and insider confidence. Recent Form 4 filings revealed changes in beneficial ownership by key executives, including the Chief Medical Officer and the CEO/CFO. These filings, dated February 13th and reporting transactions from February 11th, often signal insider confidence in the company’s future prospects. This increased confidence can lead to increased investor interest and buying pressure.

The market may be interpreting these purchases as a bullish sign regarding Palisade Bio’s future performance. Furthermore, the news articles included do not appear to be relevant to Palisade Bio or its stock. These unrelated articles likely had little to no impact on the stock’s movement. Therefore, insider activity indicated by the SEC filings is the more probable driver.

The reduced exercise price of common stock warrants, as detailed in the December 2024 prospectus supplements, could also play a role. This reduction, stemming from a reverse stock split, makes warrant exercise more appealing. This increased potential dilution could be outweighed by the perception of increased value. The exercise of warrants would bring additional capital into the company, boosting its financial position.

It is important to note that Form 4 filings can be complex, and the reported changes don’t always translate to a net positive or negative signal. Investors should always conduct thorough due diligence and consider various factors before making investment decisions. The limited information available makes a definitive attribution challenging.


This stock has shown a change of 11.90% today.
Please consider that all investment decisions carry risk;
none of the content here should be construed as financial advice.
Always do your own research or consult a professional before making investment decisions.

The information provided in this article is for informational purposes only
and does not constitute legal, tax, or investment advice.
Investing involves risk, including the potential loss of principal.

Posted by

in

Leave a Reply

Your email address will not be published. Required fields are marked *